Tandem Diabetes Care | Себестоимость



Cost Of Sales Изменить Дата
Abbott USD 4.44B 502M 2025-03
Align Technology USD 299.15M 876K 2025-03
AtriCure USD 30.99M 666K 2025-03
Baxter International USD 1.74B 73M 2024-12
Becton, Dickinson and Co. USD 2.93B 21M 2024-12
Boston Scientific USD 1.47B 5M 2025-03
Cooper Companies USD 304.5M 36.2M 2025-01
Dexcom USD 404.2M 3.8M 2024-12
Edwards Lifesciences USD 301.6M 9.4M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Globus Medical USD 263.44M 7.08M 2024-12
ICU Medical USD 402.55M 18.27M 2024-12
Insulet USD 166.6M 200K 2024-12
Integra LifeSciences USD 176.8M 14.01M 2024-12
Intuitive Surgical USD 795.7M 24.4M 2025-03
J&J USD 7.3B 189M 2025-03
Masimo USD 356M 114.6M 2024-12
Medtronic USD 2.78B 160M 2025-01
Merit Medical Systems USD 733.32M 551.15M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Stryker USD 2.24B 261M 2024-12
Tandem Diabetes Care USD 116.02M 9.18M 2025-03
Teleflex USD 311.23M 44.26M 2025-03
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12



Tandem Diabetes Care Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - May 2025.